Literature DB >> 26284446

Paget's disease of bone-genetic and environmental factors.

Frederick R Singer1.   

Abstract

Paget's disease of bone is generally diagnosed in individuals aged >50 years, usually manifests in one or several bones and is initiated by osteoclast-induced osteolytic lesions. Subsequently, over a period of many years, osteoblastic activity can result in sclerosis and deformation of bone. The prevalence of Paget's disease is highest in the UK and in countries where a large number of residents have ancestors from the UK. Currently, in many countries, the prevalence of the disorder has decreased. A considerable number of affected patients have a family history of Paget's disease and the disorder has an autosomal dominant pattern of inheritance but with incomplete penetrance. A large number of mutations in SQSTM1 (which encodes sequestosome-1; also known as ubiquitin-binding protein p62) seem to account for the susceptibility to develop Paget's disease in some families; the involvement of other genes is currently under investigation. In addition to a genetic cause, environmental factors have been proposed to have a role in the pathogenesis of Paget's disease. Although most evidence has been presented for measles virus as an aetiologic factor, some studies have not confirmed its involvement. The decreasing incidence of Paget's disease, which could be attributed to measles vaccination along with the measles virus nucleocapsid protein induction of Paget's disease lesions in transgenic mice, supports an aetiologic role of the virus.

Entities:  

Mesh:

Year:  2015        PMID: 26284446     DOI: 10.1038/nrendo.2015.138

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  114 in total

1.  Progression in length and width of pagetic lesions, and estimation of age at disease onset.

Authors:  J C Renier; M Audran
Journal:  Rev Rhum Engl Ed       Date:  1997-01

2.  Familial expansile osteolysis: a morphological, histomorphometric and serological study.

Authors:  G R Dickson; P V Shirodria; J A Kanis; M N Beneton; K E Carr; R A Mollan
Journal:  Bone       Date:  1991       Impact factor: 4.398

3.  Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.

Authors:  Sara K Custer; Manuela Neumann; Hongbo Lu; Alexander C Wright; J Paul Taylor
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

4.  Ultrastructural features of the osteoclasts from Paget's disease of bone in relation to a viral aetiology.

Authors:  L Harvey; T Gray; M N Beneton; D L Douglas; J A Kanis; R G Russell
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

5.  Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.

Authors:  Gavin J A Lucas; Sarju G Mehta; Lynne J Hocking; Tracy L Stewart; Tim Cundy; Geoff C Nicholson; John P Walsh; William D Fraser; Giles D J Watts; Stuart H Ralston; Virginia E Kimonis
Journal:  Bone       Date:  2005-09-30       Impact factor: 4.398

6.  Measles epidemics 1949-91: the impact of mass immunisation in New Zealand.

Authors:  R M Cullen; W J Walker
Journal:  N Z Med J       Date:  1996-10-25

Review 7.  Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Authors:  Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-04-19       Impact factor: 4.296

8.  Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone.

Authors:  M A Birch; W Taylor; W D Fraser; S H Ralston; C A Hart; J A Gallagher
Journal:  J Bone Miner Res       Date:  1994-01       Impact factor: 6.741

9.  Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB.

Authors:  Chun T Kwok; Alex Morris; Jacqueline S de Belleroche
Journal:  Eur J Hum Genet       Date:  2013-08-14       Impact factor: 4.246

10.  VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease.

Authors:  Mallikarjun Badadani; Angèle Nalbandian; Giles D Watts; Jouni Vesa; Masashi Kitazawa; Hailing Su; Jasmin Tanaja; Eric Dec; Douglas C Wallace; Jogeshwar Mukherjee; Vincent Caiozzo; Matthew Warman; Virginia E Kimonis
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

View more
  17 in total

Review 1.  The role of bone cells in immune regulation during the course of infection.

Authors:  Asuka Terashima; Hiroshi Takayanagi
Journal:  Semin Immunopathol       Date:  2019-09-24       Impact factor: 9.623

Review 2.  Paget's Disease of Bone.

Authors:  Luigi Gennari; Domenico Rendina; Alberto Falchetti; Daniela Merlotti
Journal:  Calcif Tissue Int       Date:  2019-01-23       Impact factor: 4.333

Review 3.  Bone Quality in Paget's Disease of Bone.

Authors:  Frederick R Singer
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

Review 4.  Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.

Authors:  Emily M Rabjohns; Katlyn Hurst; Arin Ghosh; Maria C Cuellar; Rishi R Rampersad; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-25       Impact factor: 4.806

5.  Epigenetic DNA Methylation Signatures Associated With the Severity of Paget's Disease of Bone.

Authors:  Ilhame Diboun; Sachin Wani; Stuart H Ralston; Omar M E Albagha
Journal:  Front Cell Dev Biol       Date:  2022-06-13

Review 6.  Insights into skeletal stem cells.

Authors:  Qiwen Li; Ruoshi Xu; Kexin Lei; Quan Yuan
Journal:  Bone Res       Date:  2022-10-19       Impact factor: 13.362

7.  Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.

Authors:  Emilie Laurier; Nathalie Amiable; Edith Gagnon; Jacques P Brown; Laëtitia Michou
Journal:  BMC Med Genet       Date:  2017-11-16       Impact factor: 2.103

8.  A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.

Authors:  Bingru Lu; Yulian Jiao; Yinchang Wang; Jing Dong; Muyun Wei; Bin Cui; Yafang Sun; Laicheng Wang; Bingchang Zhang; Zijiang Chen; Yueran Zhao
Journal:  Exp Mol Med       Date:  2017-05-19       Impact factor: 8.718

9.  Visual Osteoclast Fusion via A Fluorescence Method.

Authors:  Boer Li; Fanyuan Yu; Fanzi Wu; Ke Wang; Feng Lou; Demao Zhang; Xueyang Liao; Bei Yin; Chenglin Wang; Ling Ye
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

Review 10.  P62: An emerging oncotarget for osteolytic metastasis.

Authors:  Jing Zhang; Zuozhang Yang; Jian Dong
Journal:  J Bone Oncol       Date:  2016-02-03       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.